##EasyReadMore##

Thursday, December 2, 2010

Reuters Health Report

If you are having trouble viewing this email or would like to view it in your web browser, CLICK HERE

 
Good Morning Pan, THU 02 Dec 2010 
 
Brain scans accurate at spotting autism: U.S. study
Study says Huntington's tests to aid drug search
Americans make slow return to doctor's offices
J&J heartburn worsens as Mylanta joins recall list
Bayer expands research work to fight cancer in Asia
Senate Democrats criticize mini-med plans
Military's gays policy harms health, doctor says
Heart stenting on the rise in Canada
FDA declines to OK Glaxo epilepsy drug for now
Corrected: Drugmakers, academics join up on mental illness

Brain scans accurate at spotting autism: U.S. study
December 02, 2010 12:20 AM ET
CHICAGO (Reuters) - U.S. researchers are closing in on an accurate test for autism, a finding that could lead to earlier diagnosis and treatment.

Full Article
Study says Huntington's tests to aid drug search
December 01, 2010 07:09 PM ET
LONDON (Reuters) - Scientists have developed a new range of tests that allow them to track the progression of Huntington's disease long before symptoms appear and should aid the development of drugs for the incurable inherited disease.

Full Article
Americans make slow return to doctor's offices
December 02, 2010 07:37 AM ET
NEW YORK (Reuters) - Americans are slowly making their way back to the doctor's office after many months of skimping on medical care, holding off on everything from routine visits to hip replacements.

Full Article
J&J heartburn worsens as Mylanta joins recall list
December 01, 2010 07:36 PM ET
NEW YORK (Reuters) - Johnson & Johnson's consumer-product distress worsened on Wednesday as the company recalled 12 million bottles of over-the-counter Mylanta and almost 85,000 bottles of its AlternaGel liquid antacid.

Full Article
Bayer expands research work to fight cancer in Asia
December 01, 2010 11:45 PM ET
SINGAPORE (Reuters) - Bayer AG said on Thursday it had entered into five projects with scientists in Singapore to work on earlier diagnosis and treatment of cancers that are most prevalent in Asia.

Full Article
Senate Democrats criticize mini-med plans
December 01, 2010 05:52 PM ET
WASHINGTON (Reuters) - Democratic senators criticized low-cost, bare-bones health insurance plans on Wednesday, saying the plans designed for low-wage workers can be worse than no coverage at all.

Full Article
Military's gays policy harms health, doctor says
December 01, 2010 05:27 PM ET
WASHINGTON (Reuters) - The U.S. military's "Don't Ask, Don't Tell" policy for gays helps spread disease and puts service members' health at risk, a commentary by a doctor in the New England Journal of Medicine said Wednesday.

Full Article
Heart stenting on the rise in Canada
December 01, 2010 05:31 PM ET
NEW YORK (Reuters Health) - The number of Canadians having blocked heart arteries opened with a non-surgical procedure more than doubled between 1994 and 2005, mirroring trends seen in the U.S., Europe and elsewhere, according to a new study.

Full Article
FDA declines to OK Glaxo epilepsy drug for now
December 01, 2010 05:41 PM ET
NEW YORK (Reuters) - The U.S. Food and Drug Administration declined to approve an experimental epilepsy drug from GlaxoSmithKline and Valeant Pharmaceuticals International, the companies said on Wednesday, marking another delay for the anti-seizure medicine.

Full Article
Corrected: Drugmakers, academics join up on mental illness
December 02, 2010 07:35 AM ET
Corrects that Johnson & Johnson makes Risperdal, not Eli Lilly, in para 10 of story posted posted on Nov 10, 2010

Full Article
 
 











REUTERS www.reuters.com
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book.Details
Subscribe to other Reuters newsletters
Unsubscribe from this newsletter.


Forward to a friend Send this mailing to a friend or colleague


Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS RSS Feed | Interactive TV | Labs | Reuters in Second Life | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

No comments:

Not What You Were Looking For? Try a new Google Web Search